Contact person
Emmanuelle Coutanceau, Partner
Go to profile

Draupnir Bio

Investment area
Seed Investments
Region
Europe
Date of investment
October 2018

Draupnir Bio is a Danish biotechnology company developing small molecule therapeutics to transform the treatment of heart disease.

Contact person
Emmanuelle Coutanceau, Partner
Go to profile

Draupnir Bio

Investment area
Seed Investments
Region
Europe
Date of investment
October 2018

Draupnir Bio is a Danish biotechnology company developing small molecule therapeutics to transform the treatment of heart disease.

Draupnir Bio

Investment area
Seed Investments
Region
Europe
Date of investment
October 2018

Draupnir Bio is a Danish biotechnology company developing small molecule therapeutics to transform the treatment of heart disease.

Contact person
Emmanuelle Coutanceau, Partner
Go to profile